ELOXX PHARMACEUTICALS, INC. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ELOXX PHARMACEUTICALS, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2017-12-31 was $3.17M.
- ELOXX PHARMACEUTICALS, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2017-09-30 was $0.00.
- ELOXX PHARMACEUTICALS, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2017-06-30 was $0.00.
- ELOXX PHARMACEUTICALS, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2017-03-31 was $0.00.
- ELOXX PHARMACEUTICALS, INC. stock issued during period, value, conversion of convertible securities for fiscal 2017 was $3.17M.
- ELOXX PHARMACEUTICALS, INC. stock issued during period, value, conversion of convertible securities for fiscal 2017 was $0.00.
- ELOXX PHARMACEUTICALS, INC. stock issued during period, value, conversion of convertible securities for fiscal 2016 was $0.00.
- ELOXX PHARMACEUTICALS, INC. stock issued during period, value, conversion of convertible securities for fiscal 2015 was $0.00.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2017-12-31 | $3.17M derived: 10-K 12 month − 3 quarters · filed 2018-03-16 | $3.17M 10-K · filed 2018-03-16 |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-10-13 | $0.00 10-K · filed 2017-10-13 |
| 2017-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-22 | |
| 2016-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-10-13 | $0.00 10-K · filed 2017-10-13 |
| 2016-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-12 | $0.00 derived: sum of 4 quarters · filed 2017-10-13 |
| 2015-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-16 | |
| 2015-09-30 | $0.00 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-10-13 | $0.00 10-K · filed 2017-10-13 |
| 2014-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-10-13 | $0.00 10-K · filed 2016-10-13 |
| 2014-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-09 | $0.00 derived: sum of 4 quarters · filed 2015-10-09 |
| 2013-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-14 | |
| 2013-09-30 | $0.00 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-10-09 | $0.00 10-K · filed 2015-10-09 |
| 2012-06-30 | $0.00 10-K · filed 2014-09-29 | |
| 2011-06-30 | $0.00 10-K · filed 2013-09-11 | |
| 2009-06-30 | $44.93K 10-K · filed 2013-09-11 | |
| 2008-06-30 | $436.51K 10-K · filed 2013-09-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Tevogen Inc. (TVGN) | United States | $0.049B |